Jan Groen, Intravacc CEO

Dutch CD­MO In­travacc gets NIH grant of up to $14.6M to make gon­or­rhea vac­cine

To date, on­ly two gon­or­rhea vac­cines have made it in­to hu­man tri­als, with nei­ther prov­ing suc­cess­ful.

In­travacc and Ther­a­pyx hope to make the third …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.